Pfizer Inc Profit Margin
Data as of August 04, 2026
Profit Margin (TTM)
11.8%
Revenue (TTM)
$62.97B
Sector
Pharmaceuticals
Ticker
PFE
How It's Calculated
What This Means
Pfizer Inc's profit margin of 11.8% is solid for many industries, though norms vary widely in Pharmaceuticals.
About Pfizer Inc
Pfizer Inc (PFE) operates in the Pharmaceuticals sector, specifically in Pharmaceuticals. With a market capitalization of about $142.54B, it ranks as a large-cap stock — a major established company.
Shares recently traded near $25.03, within a 52-week range of $23.11 to $28.75 (-12.9% from the high, +8.3% from the low). Beta of 0.28 indicates relatively lower volatility versus the market.
Trailing profit margin is about 11.8%, signaling a solid profit margin for its industry.
Understanding This Metric
Profit margin connects income-statement quality to valuation. For Pfizer Inc, trailing margin summarizes how much revenue converts to net profit after costs. In Pharmaceuticals, margins differ by business model — software and services often run higher margins than capital-intensive industries. Track margin trends across quarters; a stable or improving margin can support earnings durability, while sharp declines may warrant deeper review of guidance and competition.
Using This Number in Practice
At about 11.8% trailing profit margin, Pfizer Inc (PFE) is in a range often seen among mature operators in its industry. For large revenue bases, even a one-point margin move can shift earnings materially, so trend matters as much as the spot reading.
When comparing PFE to alternatives, combine margin with return on equity, revenue growth, and valuation. Use our margin calculator for scenario work, and browse the PFE metrics hub plus sector peers in the comparison section above.
Sector Comparison
Among Pharmaceuticals names on our S&P 100 coverage, Pfizer Inc's profit margin of 11.8% can be compared with peers such as LLY (35.0%), JNJ (21.5%), MRK (13.6%). Sector context helps interpretation, but each company's growth profile and balance sheet differ — use multiple metrics before drawing conclusions. View all Pharmaceuticals stocks.
Key Takeaways
- PFE is grouped in the Pharmaceuticals sector for peer comparisons.
- Recent beta of 0.28 suggests lower-than-market price sensitivity.
- Trailing profit margin of 11.8% provides context for how much earnings support the headline multiple.
Related Tools & Guides
Explore calculators and guides connected to this metric, or view all metrics for PFE.
Learn the full workflow
Compare PE with PB, PEG, EV/EBITDA, and market cap in one structured path.
Open the Stock Valuation hub →Other PFE Metrics
Frequently Asked Questions
What is PFE's profit margin?
Trailing profit margin measures net income as a percent of revenue. Pfizer Inc's margin is about 11.8% on this snapshot — higher margins often support stronger valuation multiples in Pharmaceuticals.
Is 11.8% strong for Pharmaceuticals?
Peers in Pharmaceuticals such as LLY (35.0%), JNJ (21.5%), MRK (13.6%) help benchmark PFE's 11.8%. Margins vary by sub-industry and accounting cycle.
How often is profit margin updated?
Margins update after quarterly earnings; price-only fields refresh on trading days. Data as of August 04, 2026.
Calculate the profit margin for any stock with our free calculator.
Open Margin Calculator →